HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,054 | +5.8% | 27,600 | 0.0% | 0.04% | +2.3% |
| Q2 2023 | $996 | +6.4% | 27,600 | +12.7% | 0.04% | -6.4% |
| Q1 2023 | $936 | -24.2% | 24,500 | +12.9% | 0.05% | -28.8% |
| Q4 2022 | $1,235 | -99.9% | 21,700 | 0.0% | 0.07% | +40.4% |
| Q3 2022 | $858,000 | -10.2% | 21,700 | 0.0% | 0.05% | +2.2% |
| Q2 2022 | $955,000 | -9.3% | 21,700 | -17.8% | 0.05% | +17.9% |
| Q1 2022 | $1,053,000 | -0.8% | 26,400 | 0.0% | 0.04% | +8.3% |
| Q4 2021 | $1,062,000 | -1.1% | 26,400 | 0.0% | 0.04% | -2.7% |
| Q3 2021 | $1,074,000 | -10.4% | 26,400 | 0.0% | 0.04% | -9.8% |
| Q2 2021 | $1,199,000 | +27.8% | 26,400 | +17.3% | 0.04% | +10.8% |
| Q1 2021 | $938,000 | -2.4% | 22,500 | 0.0% | 0.04% | -9.8% |
| Q4 2020 | $961,000 | – | 22,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |